4.7 Letter

Reply to 'Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis'

Journal

BRITISH JOURNAL OF CANCER
Volume 101, Issue 4, Pages 738-740

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6605207

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available